持続的な抗菌療法のための多段階組み立て型ロイテリ菌カプセルパッチ
Chen Zhou1,2,3, Yuxiang Wang1,2, Ming Yang3
1National Engineering Research Center for Biomaterials, Sichuan University, 29 Wangjiang Road, Chengdu, Sichuan, 610064, P. R. China. sunyong8702@scu.edu.cn.
Abstract:
Recurrent bacterial invasion delays the healing of infected sites; therefore, the development of a sustained antibacterial therapeutic strategy is essential. Herein, we use one simple multi-stage assembly strategy to develop a Lactobacillus reuteri-capsule patch that could achieve sustained antibacterial applications. The encapsulated strain retains its activity within the sodium alginate (SA) capsule, showing sustained release in response to pH changes in the infection microenvironment. In addition, the nanofiber structure of bacterial cellulose (BC) prevented contact between the strains and the lesion to avoid additional inflammatory reactions (the isolation rate reached 99.9%). The patch exhibited a sustained antibacterial effect against the formation of common pathogen biofilms by hindering biosynthesis (including E. coli, S. aureus, MRSA and P. aeruginosa), which avoided recurrent bacterial invasion. Transcriptomics results demonstrate that the patch exhibits various bioactivities to promote proliferation, migration and vascularization, in contrast with traditional antibiotic therapy. In vivo infection model verification further demonstrates that this patch effectively clears biofilms to prevent the recurrent invasion of P. aeruginosa, while achieving substantial tissue regeneration through collagen deposition and neovascularization. This strategy provides a simple and efficient approach for persistent anti-infection application.
さらに関連する動画
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
関連する概念動画
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Drug Delivery Systems: Delayed-Release Systems
Drugs for Treatment of Constipation-Predominant IBS
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
